CSIR Launches 'Scientifically Validated' Ayurveda Drug For Type 2 Diabetes

A Council of Scientific and Industrial Research (CSIR) lab in Lucknow is set to release an anti-diabetes herbal drug, christened BGR-34, on Sunday, according to a Times of India report.

This scientifically-validated drug, that costs Rs 500 for a pack of 100, is expected to be available within a fortnight, said the marketing head of Aimil Pharmaceuticals (UP and Delhi), VS Kapoor.

Experts who have developed the drug say that it powers the immunity system, and also works as an antioxidant. The product of a collaboration between two CSIR labs, BGR-34 also aids the maintenance of blood glucose levels.

According to Dr AKS Rawat, a senior principal scientist at NBRI (one of the labs), the drug features the extracts from four Ayurvedic plants. It has been tested on animals and found effective with clinical trials showing 67 per cent success.

Like Us On Facebook |
Follow Us On Twitter |
Contact HuffPost India



The Best Of Gaurav Ghera's 'Shopkeeper' Series